Dr. Lal PathLabs

Dr. Lal PathLabs EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Dr. Lal PathLabs (LALPATHLAB.NS) as of Oct 24, 2026 is 6.21 B INR. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 7.89 B INR — a change of -21.30% (lower).

EBITDA

6.21 BINR

YoY

-21.30%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Dr. Lal PathLabs is 2026 6.21 B INR. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Dr. Lal PathLabs was 2025 7.89 B INR. It decreases by -21.30% lower compared to the previous year.

The Dr. Lal PathLabs EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2019
4.51 B INR
Jan 1, 2020
5.18 B INR
Jan 1, 2021
4.88 B INR
Jan 1, 2022
8.45 B INR
Jan 1, 2023
5.02 B INR
Jan 1, 2024
6.78 B INR
Jan 1, 2025
7.89 B INR
Jan 1, 2026
6.21 B INR
The Dr. Lal PathLabs EBITDA history
YEAREBITDAYoY
6.21 BINR-21.30%
7.89 BINR+16.30%
6.78 BINR+35.18%
5.02 BINR-40.65%
8.45 BINR+73.33%
4.88 BINR-5.84%
5.18 BINR+14.90%
4.51 BINR+13.89%
3.96 BINR+15.40%
3.43 BINR+62.85%
2.11 BINR+34.83%
1.56 BINR+10.81%
1.41 BINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Dr. Lal PathLabs Stock analysis

What does Dr. Lal PathLabs do? Dr. Lal PathLabs Ltd is a leading diagnostic company in India, offering a wide range of tests and services. The company was founded in 1949 by Dr. S.K. Lal in Delhi and has since expanded its services throughout India. Business Model: The business model of Dr. Lal PathLabs Ltd is based on offering diagnostic test packages for various diseases and disorders. Customers can choose from different test packages tailored to their specific needs. The company utilizes state-of-the-art technology and equipment in its laboratories to deliver accurate results. Another important pillar of the business model is close collaboration with doctors and clinics to improve customer care and provide comprehensive medical services. Company History: Dr. Lal PathLabs Ltd began its journey in 1949 in Delhi, India, when Dr. S.K. Lal founded the company. It was one of the few private laboratories capable of conducting diagnostic tests and was a pioneer in developing modern technology and equipment to support the tests. Over the years, the company has expanded its operations and services and is now one of the leading diagnostic companies in India. It is known for its precise test results, excellent customer care, and innovative technology. Segments: Dr. Lal PathLabs Ltd offers a wide range of diagnostic tests and services. The various segments covered by the company include: 1. Clinical Pathology: This segment covers a wide range of tests targeting the customers' health condition. They include blood tests, urine and stool tests, hormone tests, diabetes checks, pregnancy tests, and more. 2. Microbiology: This segment deals with the identification of pathogens such as bacteria, viruses, fungi, and parasites found in tests of body fluids and tissue samples. 3. Histology: This segment covers the identification of tissue samples and cells. It is used in the diagnosis of cancer, thyroid disorders, and other diseases. 4. Immunology: Tests are conducted based on antibodies to diagnose autoimmune diseases, infectious diseases, and allergies. 5. Genetics: This segment deals with the diagnosis of genetic diseases and genetic testing for disease prevention. Products: Dr. Lal PathLabs Ltd offers a wide range of diagnostic test packages customized to individual customer needs. Some of the key test packages include: 1. Pro 1: This test package provides a comprehensive evaluation of all key parameters, including cholesterol, blood pressure, and uric acid. 2. Essential Health Checkup: This test package is designed for checking heart health and includes tests such as electrocardiogram (EKG), lipid profile, and complete blood count. 3. Diabetic Profile: This test package is specifically designed for diabetics and includes tests such as HbA1c, kidney function tests, and lipid profile. 4. Comprehensive Health Checkup: This test package offers a comprehensive evaluation of all key parameters, including cholesterol, blood pressure, blood sugar, and uric acid. Dr. Lal PathLabs Ltd has established itself as a leading diagnostic company in India and is known for its high accuracy in test results and innovative technology. The company is committed to improving medical care and works closely with doctors and clinics to provide comprehensive medical services. Dr. Lal PathLabs is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Dr. Lal PathLabs stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Dr. Lal PathLabs is 6.21 B INR in 2026.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Dr. Lal PathLabs changed from 7.89 B INR to 6.21 B INR, representing a -21.30% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Dr. Lal PathLabs since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Dr. Lal PathLabs historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Dr. Lal PathLabs

All Key Metrics — Dr. Lal PathLabs